Credit Suisse Maintains Neutral on SOC Telemed, Raises Price Target to $3
$TLMD
Managed Health Care
Health Care
Credit Suisse analyst Jailendra Singh maintains SOC Telemed (NASDAQ:TLMD) with a Neutral and raises the price target from $2 to $3.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/1/2022 | $3.00 | Neutral | Credit Suisse |
| 2/7/2022 | $2.00 → $3.00 | Neutral | Credit Suisse |
| 2/4/2022 | Buy → Hold | Benchmark | |
| 2/3/2022 | $6.00 → $3.00 | Outperform → Sector Perform | RBC Capital |
| 2/3/2022 | $4.00 → $3.00 | Outperform → Neutral | Baird |
| 1/7/2022 | $6.00 → $2.00 | Outperform → Neutral | Credit Suisse |
| 8/13/2021 | $10.00 → $6.00 | Outperform | RBC Capital |
| 8/13/2021 | $11.00 → $8.50 | Outperform | Credit Suisse |
RESTON, Va., Nov. 12, 2021 /PRNewswire/ -- SOC Telemed, Inc., (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating results for the third quarter ending September 30, 2021. SOC Telemed Reports Third Quarter 2021 Financial and Operating Results "We are proud of our third quarter results as the new organization came together with renewed focus resulting in the highest quarterly revenue and bookings in our company's history," said Dr. Chris Gallagher, Chief Executive Officer. "Upon joining the Company, my first task h
RESTON, Va., Oct. 29, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the company will provide a corporate and financial update for the third quarter 2021, on Friday, November 12, 2021, before market open. SOC Telemed's management team will host a conference call and live audio webcast at 8:00 a.m. ET. To participate in the call, dial either the domestic or international number or join the webcast from your computer or mobile phone. Domestic: (877) 292-0959 International: (412) 542-4143 Passco
RESTON, Va., Sept. 7, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the Company will host an introductory conference call with new leadership, which was announced on September 1, 2021. Dr. Chris Gallagher, CEO of the Company, and Joe Greskoviak, Vice Chairman of the Board of Directors, will host the call on Thursday, September 9, 2021, at 5 p.m. ET. Dial-In Numbers Domestic: (877) 292-0959 International: (412) 542-4143 Passcode: please ask to join the SOC Telemed call A live audio webcast w
Credit Suisse resumed coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00
Credit Suisse reiterated coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00 from $2.00 previously
Benchmark downgraded SOC Telemed from Buy to Hold
Veteran Legal Executive Brings More Than Two Decades of Experience in Private and Public Sector Regulatory Affairs, Ethics and Compliance to Unified Defense SIEM Leader Securonix, Inc., a leader in Unified Defense SIEM, today announced the appointment of Eunice Kim as general counsel. In this role, Kim will be responsible for leading Securonix's legal and compliance functions, enhancing processes for evaluating expansion and growth opportunities, and implementing corporate policies that support the company's mission, vision and values. "Eunice is a dynamic legal executive, and we are thrilled to welcome her to Securonix," said Nayaki Nayyar, Chief Executive Officer, Securonix. "Her prov
HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022. Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warr
HERNDON, Va., April 4, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that its stockholders approved the acquisition of SOC Telemed by Patient Square Capital, a leading dedicated health care investment firm, at a special meeting. Steve Shulman, Chairman of the SOC Telemed Board of Directors, said, "On behalf of the SOC Telemed Board, I would like to thank our stockholders for their support of this transaction. Today's vote represents an important milestone towards
SOC Telemed (NASDAQ:TLMD) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 2 0 0 2M Ago 0 0 1 0 0 3M Ago 0 0 0 0 0 These 4 analysts have an average price target of $2.75 versus the current price of SOC Telemed at $2.835, implying downside. Below is a summary of how these 4 analysts rated SOC Telemed over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the move negative analysts are on the stock This current average represents a 38.8
Credit Suisse analyst Jailendra Singh maintains SOC Telemed (NASDAQ:TLMD) with a Neutral and raises the price target from $2 to $3.
15-12B - SOC Telemed, Inc. (0001791091) (Filer)
EFFECT - SOC Telemed, Inc. (0001791091) (Filer)
EFFECT - SOC Telemed, Inc. (0001791091) (Filer)
SC 13D/A - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G - SOC Telemed, Inc. (0001791091) (Subject)
SC 13G/A - SOC Telemed, Inc. (0001791091) (Subject)
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology services and solutions, announced today that Anne McGeorge, former Managing Partner of Grant Thornton’s Global Health Care and Life Sciences Practices, has joined its Board of Directors and chair of the Audit Committee. Ms. McGeorge comes with over 35 years of experience advising healthcare clients in all aspects of finance and transformational change, including strategy, M&A, joint ventures, financial statement audits, corporate restructuring, governance, talent acquisition, executive compensation, IRS matters and risk management. She created the healthcare / life sciences practice for Gran
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)
4 - SOC Telemed, Inc. (0001791091) (Issuer)